TY  - JOUR
PY  - 2022//
TI  - Author response to Myran and Finkelstein [concerning edible cannabis products]
JO  - Pediatrics
A1  - Yeung, Matthew E. M.
A1  - Lang, Eddy
SP  - ePub
EP  - ePub
VL  - ePub
IS  - ePub
N2  - We thank Myran and Finkelstein for their thoughtful comments on our article studying the impact of national cannabis legislation on pediatric cannabis-related emergency department (ED) visits.1 We agree with the suggestion that our study did not fully study the impact of the legalization of edible cannabis products for commercial sale, particularly as we did not collect data with sufficient lead time between changes in legislation and analysis of change. Because at the time of publishing, data were heavily confounded because of the impact of coronavirus disease 2019 (COVID-19), we chose not to look at pediatric cannabis-related visits during this time. Thus, we agree that interpretation of our findings does require an awareness that data reflected an immature time period in the commercial sale of edible cannabis products.     However, we were able to look at data from a provincial database looking broadly at the urban zones in Alberta. From February 1, 2020 to November 30, 2020, we did not identify the same ninefold increase suggested by Myran and Finkelstein. In fact, we identified 28.5 visits among those aged 15 to 17 per month, and 11.1 visits per month among those aged 0 to 14. We note these numbers are comparable to our prelegalization averages for those aged 0 to 14 and 15 to 17, at 9.6 visits per month and 25.8 visits per month, respectively, and to our postlegalization averages for those aged 0 to 14 and 15 to 17 at 6.4 visits per month and 25.6 visits per month, respectively.     Nonetheless, we believe there are many confounding factors to any association between the legalization of commercial sale of edible cannabis products and pediatric cannabis-related ED visits. In particular, COVID-19 drove up the sale of cannabis products while also decreasing the likelihood parents would seek emergency care for children suffering from cannabis ingestion...<p />  <p>Language: en</p>
LA  - en
SN  - 0031-4005
UR  - http://dx.doi.org/10.1542/peds.2022-057638B
ID  - ref1
ER  -